Canonical: https://ownershiptrace.com/13f/companies/1082

# Who owns HAEMONETICS CORP (HA)? Elite investor 13F holders

6 tracked elite investors reported holding HAEMONETICS CORP as of 2026-06-30, including Ariel Investments, D.E. Shaw, Renaissance Technologies LLC, Bridgewater Associates, Gotham Asset Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

6 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Health Care Equipment & Services

Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions. The company operates through Plasma, Blood Center, and Hospital segments. It provides automated plasma collection systems, donor management software, and supporting software solutions, such as NexSys PCS plasmapheresis equipment system and related disposables and solutions, as well as…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [Ariel Investments](https://ownershiptrace.com/13f/investors/47) | HAEMONETICS CORP MASS | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 154572450.00 USD | 2060966.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/936753/0000936753-26-000050-index.html) |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | HAEMONETICS CORP MASS | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 2703000.00 USD | 36040.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |
| [Renaissance Technologies LLC](https://ownershiptrace.com/13f/investors/63) | HAEMONETICS CORP MASS | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 9750000.00 USD | 130000.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1037389/0001037389-26-000059-index.html) |
| [Bridgewater Associates](https://ownershiptrace.com/13f/investors/8) | HAEMONETICS CORP MASS | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 4479975.00 USD | 59733.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1350694/0001350694-26-000003-index.html) |
| [Gotham Asset Management](https://ownershiptrace.com/13f/investors/94672) | HAEMONETICS CORP MASS | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 1521675.00 USD | 20289.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1510387/0001398344-26-014644-index.html) |
| [Oaktree Capital Management](https://ownershiptrace.com/13f/investors/44) | HAEMONETICS CORP | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 2123022.00 USD | 2090000.000000 | Principal | add | [Original filing](https://www.sec.gov/Archives/edgar/data/949509/0000949509-26-000005-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)